While the maintenance of a Buy rating suggests continued confidence in Guardant Health's fundamentals and potential growth, the reduction in the price target could reflect adjustments in valuation metrics, market conditions, or company-specific factors. This mixed signal might lead to short-term volatility in the stock as investors reassess their expectations based on the new price target.